Our Mission

here we will

Hill Research leverages Generative AI to accelerate the last mile of clinical trials for pharmaceutical companies. From trial design to FDA submissions, we provide end-to-end AI-driven solutions, including intelligent decision support, compliance optimization, and safety predictions. Powered by a multi-agent large language model (LLM) tree, we enable pharmaceutical companies to shorten clinical trial cycles, streamline trial operations, and significantly increase drug approval success rates.

we are here for Life Sciences

Our solutions provide data, software, services, and an extensive ecosystem to support your most critical functions from R&D through commercial.

Hill Research helps companies of all sizes bring products to market faster and more efficiently, and maintain compliance.

Locations

Our Team

Louise Liu, PhD, MBA

CEO, Co-FOunder

12 years experience in Biostats Industry
AI Serial Entrepreneur
Post-Doc at Yale in Biostats

Rui Li, PhD

CTO, CO-FOUNDER

•10 years of experience in the Tech/AI Industry

•Multiple award-winning papers on AI

•Yale P.hD. in Big Data Computation

Alex D., PhD

CSO, CO-FOUNDER

10 years of experience in Clinical Trial Design and Biotechnology Industry
Team Leader at Flagship Pioneering

Post-Doc at Yale School of Medicine

Rui Wu, PhD

CAIO

University of Cambridge Ph.D. in AI
Lead of multiple AI projects and papers

Customer Feedbacks

““The Hill Research team excels at transforming GenAI expertise into impactful solutions, revolutionizing healthcare across drug discovery, patient recruitment, and evidence generation with a holistic approach. I’m excited to continue our collaboration.””

— Client, Partner of a renowned healthcare company

““Hill Research leverages AI to boost efficiency and success rates in pharma, with a human-centered approach that enhances decision-making and team confidence. We’re excited to continue collaborating.””

— Client, VP at a leading US pharmaceutical company